期刊文献+

抗血小板治疗对老年人胃肠道损伤的临床分析 被引量:8

Clinical analysis of antiplatelet therapy-induced gastrointestinal injury in the elderly
原文传递
导出
摘要 目的比较单用和联用抗血小板药物对老年人胃肠道损伤的风险,总结抗血小板治疗致胃肠黏膜损伤内镜特点。方法对577例使用阿司匹林和(或)氯吡格雷的老年患者消化不良症状、消化道出血事件及内镜检查结果进行回顾性分析。结果氯吡格雷组出现消化不良症状和消化道出血风险略高于阿司匹林组,但差异无统计学意义(X^2=0.48、0.72,均P〉0.05),OR值(95%CI)分别为1.10(0.59~2.07)、1.74(0.48~6.33);阿司匹林+氯吡格雷组(联用组)有消化不良症状者较单用阿司匹林或氯吡格雷组无显著增加(X^2=0.37、0.03,均P〉0.05),但消化道出血显著高于阿司匹林组(X^2=5.43,P〈0.05),OR值(95%CI)4.77(1.15~19.79),略高于氯吡格雷组(P〉0.05)。本组胃镜检查57例,糜烂或溃疡总检出率为45例(78.9%);糜烂多发生于胃窦部(61.4%),溃疡多发生于胃窦、胃角(10.6%)及十二指肠球部溃疡(18.O%);有消化不良症状者内镜下以糜烂为主(70.5%),消化道出血者则以溃疡为主(69.2%)。结论老年患者单用氯吡格雷发生消化不良症状及出血者,比单用小剂量阿司匹林者未见减少,阿司匹林+氯吡格雷联合使用可增加胃肠道出血的风险。抗血小板治疗有症状者内镜下糜烂或溃疡的检出率高,有消化不良症状者以糜烂为主,消化道出血者以溃疡为主,且复合溃疡多见。 Objective To compare the risk effects of different antiplatelet therapies on gastrointestinal injury and summarize the endoscopic characteristics of gastrointestinal mucosal injury in the elderly. Methods The dyspepsia symptoms, gastrointestinal bleeding and endoscopic findings were retrospectively evaluated among 577 patients who received the antiplatelet therapy with aspirin and/or clopidogrel. Results The risk of dyspepsia symptoms and gastrointestinal bleeding was slightly higher in clopidogrel group than in aspirin group (both P〉0.05,X^2=0.48, 0.72), and OR (95% CI): 1.10 (0.59-2.07) and 1.74 (0.48-6.33), for the risk of dyspepsia symptoms and gastrointestinal bleeding, respectively. In aspirin plus clopidogrel group, the risk of dyspepsia symptoms had no significant increase as compared with aspirin or clopidogrel group (X^2=0.37, 0.03, for aspirin or clopidogrel group, respectively, both P〉0.05), but the risk of gastrointestinal bleeding was significantly higher than in aspirin group (X^2= 5.43, P〈0.05), OR (95%CI): 4.77 (1.15-19.79) and slightly higher than in clopidogrel group (P〉0.05). In this study, 57 patients received endoscopy and the detection rate of erosion or ulcer was 78.9%. Erosion (61.4%) was most in the gastric antrum; gastric ulcer (10.6%) located in gastric antrum and angle; duodenal ulcer (18.0%) located in bulb. In patients with dyspepsia symptoms erosion (70.5%), were most likely found but patients with gastrointestinal bleeding showed mainly ulcer (69.2%). Conclusions In the elderly the use of clopidogrel alone is not safer than low-dose aspirin and the combination would increase the risk of gastrointestinal bleeding. The detection rate of erosion or ulcer is high in patientswith symptoms. Patients with dyspepsia symptoms most likely show erosion, but patients with gastrointestinal bleeding have mainly ulcer and complex ulcers more common.
作者 周海娟 张玉
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2011年第5期358-361,共4页 Chinese Journal of Geriatrics
关键词 阿司匹林 血小板聚集抑制剂 胃肠疾病 Aspirin Platelet aggregation inhibitors Gastrointestinal injury
  • 相关文献

参考文献11

  • 1Bhatt DL,Scheiman J, Abraham NS, et al. ACCF/ ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation,2008,118: 1894-1909.
  • 2Anderson JL,Adams CD, Antman EM, et al. ACC/ AHA 2007 guidelines for the management of patients with unstable angina/non- ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol, 2007,50:1- 157.
  • 3王晓林,熊枝繁,曹仕琼.不同阿司匹林肠溶片对老年人上消化道黏膜影响的比较[J].中华老年医学杂志,2009,28(1):55-57. 被引量:12
  • 4陈慧,张艳,吴小盈,孙红.肠溶阿司匹林致冠心病患者上消化道出血不良反应调查[J].中华临床医师杂志(电子版),2010,4(8). 被引量:49
  • 5CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemicevents (CAPRIE). Lancet, 1996, 348:1329-1339.
  • 6Ziegelin M, Hoschtitzky A, Dunning J, et al. Does clopidogrel rather than aspirin plus a proton-pump inhibitor reduce the frequency of gastrointestinal complications after cardiac surgery? Interact Cardiovasc Thorac Surg, 2007, 6:534-537.
  • 7Ng FH,Wong SY, Chang CM, et al. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther, 2003,18:443-449.
  • 8Buresly K, Eisenberg M J, Zhang X, et al. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med, 2005,165:784 -789.
  • 9Steinhubl SR, Berger PB, Mann JT, et al. CREDO investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA, 2002,288:2411 2420.
  • 10Niv Y, Battler A, Abuksis G, et al. Endoscopy in asymptomatic minidose aspirin consumers. Dig Dis Sci, 2005,50:78-80.

二级参考文献30

共引文献56

同被引文献66

  • 1惠波,王小飞,王旭,王正忠,夏大胜,邵一兵,党群.氯吡格雷在经皮冠状动脉介入治疗中的应用[J].中华老年心脑血管病杂志,2005,7(5):322-323. 被引量:3
  • 2韩雅玲,肖艳平,邓捷,李成洋,徐凯.三联抗血小板药物对缺血性脑血管病患者冠状动脉介入治疗术后的近期疗效[J].中华老年心脑血管病杂志,2007,9(3):149-151. 被引量:5
  • 3中华医学会心血管病学分会.经皮冠状动脉介入治疗指南[J].中华心血管病杂志,2009,37:2-25.
  • 4Borden WB, Redberg RF, Mushlin AI, et al. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA, 2011, 305 : 1882-1889.
  • 5Verheugt FW, Clappers N. Incidence of severe bleeding with long term clopidogrel-aspirin combination: comparison with chronic warfarin therapy [-abstract2. Circulation, 2007, 116 (Suppl II) : 441.
  • 6Bhatt DL,Scheiman J, Abraham NS, et al. ACCF/ ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Anti-platelet Therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol, 2008, 52:1502 1507.
  • 7Anderson JL, Adamas CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/non-ST-elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart association Task Force on Practice Guidelines ( Writing Committee to revise the 2002 Guidelines for the Management of Patients with Unstable Angina/non- ST-elevation Myocardial Infarction). J Am Coll Cardiol , 2007, 50: 152-157.
  • 8Terpending C. An appraisal of dual anti-platelet therapy with Clopidogrel and Aspirin for prevention of cardiovascular events. J Am Board Faro Med, 2009, 22 =51-56.
  • 9Lopez Farre A,Caramelo I, Esteven A, et al. Effect of Aspirin platelet neutrphil interactions, role of nitric oxide and eondothelin-1. Circulation, 1995, 91 : 2080-2088.
  • 10Monaco C,Mathur A, Martin JF. What causes acute coronary syndromes? Applying Koch's postulates. Atherosclerosis, 2005, 179: 1-15.

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部